Quest Diagnostics Incorporated ($DGX) Stock Forecast: Down 0.6% Today

What is Quest Diagnostics Incorporated?

Quest Diagnostics (DGX) is a leading provider of diagnostic testing, information, and services, with a market capitalization of $18.63 billion. The stock has shown strong performance over the past 5 years, outperforming the market significantly.

Why is Quest Diagnostics Incorporated going down?

DGX stock is down 0.6% on Jul 23, 2025 14:46

• Despite surpassing Q2 earnings and revenue estimates, Quest Diagnostics (DGX) witnessed a bearish market movement.
• The market potentially reacted negatively due to profit-taking by investors following a 3.2% rise in pre-market trading post the positive earnings results.
• Investors might have anticipated higher numbers or future guidance, leading to a sell-off after the earnings announcement.
• The robust historical performance of Quest Diagnostics possibly elevated expectations to a level where meeting estimates was insufficient to maintain the bullish momentum, resulting in today's bearish movement.

DGX Price Chart

DGX Technical Analysis

DGX News

Quest Diagnostics Q2 Earnings - Quest Diagnostics ( NYSE:DGX )

Q1 revenue rose 15.2% Y/Y to $2.76B, beating the $2.73B estimate; EPS of $2.62 topped the $2.58 consensus. Quest raised 2025 revenue forecast to $10.80 billion-$10.92 billion and EPS to $9.63-$9.83, above prior guidance and consensus.

https://www.benzinga.com/markets/earnings/25/07/46553159/quest-diagnostics-raises-outlook-but-warns-of-tariff-and-medicare-act-risks

Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises

DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.

https://www.zacks.com/stock/news/2602868/quest-diagnostics-beats-q2-earnings-revenue-estimates-stock-rises

Quest Diagnostics ( DGX ) Beats Q2 Earnings and Revenue Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of +1.95% and +1.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2602724/quest-diagnostics-dgx-beats-q2-earnings-and-revenue-estimates

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Quest Diagnostics ( NYSE:DGX )

Quest Diagnostics DGX has outperformed the market over the past 5 years by 493.73% on an annualized basis producing an average annual return of 508.21%. Currently, Quest Diagnostics has a market capitalization of $18.63 billion.

https://www.benzinga.com/insights/news/25/07/46526180/1000-invested-in-this-stock-5-years-ago-would-be-worth-this-much-today

Will Quest Diagnostics ( DGX ) Beat Estimates Again in Its Next Earnings Report?

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

https://www.zacks.com/stock/news/2589136/will-quest-diagnostics-dgx-beat-estimates-again-in-its-next-earnings-report

Trending Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

Dogecoin ($DOGE) Crypto Forecast: Up 6.7% Today

Quest Diagnostics Incorporated Price History

30.00.2025 - DGX Stock was up 6.5%

• The company reported strong fourth-quarter earnings and revenue that exceeded analyst expectations, showcasing robust performance in their core business.
• Despite the positive financial results, the stock initially experienced a dip, potentially influenced by profit-taking or short-term market fluctuations.
• Quest Diagnostics' improved margins demonstrate effective cost management and enhanced operational efficiency, which may have contributed to the positive movement in the stock.
• Investors reacted favorably to the company's overall solid financial performance, leading to the bullish market activity observed.

30.00.2025 - DGX Stock was up 5.1%

• Q4 earnings and revenues for Quest Diagnostics (DGX) exceeded estimates, reflecting strong financial performance.
• The positive earnings surprise is likely to have bolstered investor confidence in the company's growth prospects.
• Strong quarterly results may have drawn new investors and increased buying interest in DGX shares.
• The better-than-expected performance could indicate a positive outlook for Quest Diagnostics, potentially leading to further price appreciation in the stock.

22.09.2024 - DGX Stock was up 6.2%

• Quest Diagnostics (DGX) displayed a strong bullish movement after surpassing third-quarter financial expectations and providing positive revenue guidance for FY24.
• The company's exceptional performance in Q3, exceeding consensus on adjusted earnings per share and showing significant year-over-year sales growth, led to a favorable market response towards DGX.
• Optimistic future earnings growth prospects from the CEO and successful acquisition of new customers bolstered investor confidence in Quest Diagnostics.
• The favorable reaction to Quest Diagnostics' outperformance in earnings and revenue outlook bodes well for its stock, in contrast to the modest decline in Myriad Genetics shares following a partnership announcement.

22.09.2024 - DGX Stock was up 5.2%

• Quest Diagnostics (DGX) exceeded Q3 earnings and revenue estimates, indicating strong financial performance and investor confidence in the company's growth prospects.
• The positive earnings surprise may have fueled investor optimism and attracted more buyers to the stock, driving the bullish movement.
• The company's ability to outperform expectations suggests efficient management and a competitive position in the healthcare industry, contributing to the upward momentum in the stock price.
• Overall, the market responded positively to Quest Diagnostics' robust financial results, setting a bullish tone for the stock in the near term.

19.02.2025 - DGX Stock was down 5.1%

• Quest Diagnostics (DGX) experienced a bearish movement today.
• Aveanna (AVAH) surging 6.2% might have diverted investor attention away from DGX.
• The lack of positive earnings estimate revisions for Aveanna could have prompted investors to move funds out of DGX and into more promising opportunities.
• The shift in focus towards Aveanna's potential gains may have contributed to the bearish movement in Quest Diagnostics (DGX) today.

23.06.2025 - DGX Stock was down 0.6%

• Despite surpassing Q2 earnings and revenue estimates, Quest Diagnostics (DGX) witnessed a bearish market movement.
• The market potentially reacted negatively due to profit-taking by investors following a 3.2% rise in pre-market trading post the positive earnings results.
• Investors might have anticipated higher numbers or future guidance, leading to a sell-off after the earnings announcement.
• The robust historical performance of Quest Diagnostics possibly elevated expectations to a level where meeting estimates was insufficient to maintain the bullish momentum, resulting in today's bearish movement.

22.06.2025 - DGX Stock was up 5.2%

• Over the past 5 years, Quest Diagnostics (DGX) has delivered impressive performance, surpassing the market with an average annual return of 508.21%.
• The positive market movement of Quest Diagnostics is possibly influenced by expectations of beating earnings estimates in the upcoming report.
• Investor sentiment towards Quest Diagnostics remains upbeat due to its solid historical performance and growth potential in the diagnostic testing sector.

21.04.2025 - DGX Stock was down 5.1%

• Today's decline in DGX's stock price could be linked to profit-taking by investors following the recent surge.
• The market reaction might be influenced by broader economic conditions or specific news affecting the healthcare sector, resulting in a temporary downturn for DGX.
• Investors may be reevaluating their positions in DGX after the recent uptrend, causing a short-term decrease in the stock price.

22.03.2025 - DGX Stock was up 7.7%

• Quest Diagnostics (DGX) stock showed a strong bullish movement.
• The company surpassed expectations with its first quarter 2025 earnings and revenues, outperforming analyst projections.
• The stock's upward trend can be attributed to the favorable earnings report and sustained growth over the past 5 years.
• Investor optimism in Quest Diagnostics' performance and market position is likely driving the stock price increase.

22.03.2025 - DGX Stock was up 5.8%

• Strong Q1 earnings and revenues exceeded expectations, signaling robust financial performance and potentially favorable future outlook.
• Over the last 5 years, the stock has consistently outperformed the market, demonstrating steady growth and investor trust.
• Although there was a minor decline in stock price in the past month, the significant rise over the last year indicates sustained positive momentum.
• Anticipated earnings growth is reinforcing the bullish trend, implying ongoing profitability and investor confidence in the company's prospects.

22.03.2025 - DGX Stock was up 8.2%

• Quest Diagnostics (DGX) experienced a robust upward movement today.
• The company exceeded earnings expectations for the first quarter, resulting in a notable surge in its stock price.
• Over the past 5 years, Quest Diagnostics has consistently outperformed, showcasing an impressive average annual return that has likely boosted investor confidence and interest in the stock.
• Strong earnings and revenue results for the quarter ending in March 2025 indicate a solid performance by the company, potentially fueling additional investor confidence and driving the stock price upwards.

22.06.2025 - DGX Stock was up 6.0%

• Quest Diagnostics (DGX) exceeded Q2 earnings and revenue estimates, showcasing a 15.2% revenue growth and a significant EPS beat, leading to a 3.2% rise in the stock price.
• The company's consistent outperformance over the past 5 years, with an impressive annualized return of 508.21%, has likely contributed to investor confidence and positive market sentiment.
• With a history of surpassing earnings expectations and favorable market conditions, Quest Diagnostics (DGX) appears well-positioned to continue its upward trajectory, attracting further investor interest and driving the bullish movement in the stock price.